Terminated PHASE4 INTERVENTIONAL 2-arm NCT00983645

A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity

A Prospective, Open-label, Randomized Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity

Sponsor: Loma Linda University

Conditions Renal Transplant Rejection

Interventions Neoral Prograf

Updated 9 times since 2017 Last updated: Apr 28, 2016 Started: Oct 31, 2004 Primary completion: Oct 31, 2012 Completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insufficient funding

Other terminated trials from Loma Linda University

See all terminations from Loma Linda University

Listed as NCT00983645, this PHASE4 trial focuses on Renal Transplant Rejection and remains terminated or withdrawn. Sponsored by Loma Linda University, it has been updated 9 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2023 — Jul 2024 [monthly]

Terminated PHASE4
Dec 2022 — Jan 2023 [monthly]

Terminated PHASE4
Dec 2021 — Dec 2022 [monthly]

Terminated PHASE4

▶ Show 4 earlier versions

Jan 2021 — Dec 2021 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE4
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE4

First recorded

Oct 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Loma Linda University

Data source: Loma Linda University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Loma Linda, United States